GlassScriptPhysician profile
Jenna M Walker
NPI 1558022079
$6,828.11
in general payments reported to CMS, 2019-2025
29 companies · $2,440 in 2025
The $2,440 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,055 · 2023: $1,490 · 2024: $1,843 · 2025: $2,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,785 · Travel and Lodging: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,785.29 |
| Travel and Lodging | $988.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,785.54 | 2023-2025 | Watchman Access System, Watchman Flx, Bodyguardian |
| Janssen Pharmaceuticals, INC | $852.41 | 2023-2024 | Xarelto |
| Amgen INC. | $675.98 | 2022-2025 | Repatha, Repatha, Enbrel |
| Boehringer Ingelheim Pharmaceuticals, INC. | $559.26 | 2023-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $482.60 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $323.43 | 2022-2024 | Farxiga, Saphnelo |
| Medtronic, INC. | $315.79 | 2024-2025 | Linq II, Cobalt Dr Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $265.18 | 2024-2025 | Camzyos |
| Esperion Therapeutics, INC. | $199.14 | 2023-2025 | Nexletol, Nexlizet |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $163.31 | 2023-2025 | Lifevest |
| Ucb, INC. | $162.69 | 2022-2023 | Cimzia |
| Abbvie INC. | $158.76 | 2022-2023 | |
| Cvrx, INC. | $154.71 | 2024-2025 | Barostim Neo System |
| Atricure, INC. | $153.31 | 2024 | |
| Merck Sharp & Dohme LLC | $115.45 | 2023-2025 | Verquvo |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $86.45 | 2022 | |
| Pfizer INC. | $67.70 | 2022-2025 | |
| Novo Nordisk INC | $45.02 | 2024 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $39.65 | 2024 | |
| Horizon Therapeutics Plc | $35.40 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.76 | 2025 | |
| Abiomed | $24.57 | 2024 | Impella |
| Actelion Pharmaceuticals US, INC. | $23.09 | 2023 | Opsumit |
| Bioventus LLC | $22.22 | 2022 | |
| Alnylam Pharmaceuticals INC. | $20.11 | 2023 | Onpattro |
| Zimmer Biomet Holdings, INC. | $19.75 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.58 | 2022 | |
| Scpharmaceuticals INC. | $17.74 | 2023 | |
| Sobi, INC | $13.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.